Indiana University Health Melvin And Bren Simon Cancer Center — Indianapolis, Indiana

Indiana University Health Melvin And Bren Simon Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Indiana University Health Melvin And Bren Simon Cancer Center has participated in 5 clinical trials.

Therapeutic areas: Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line, Renal Cell Carcinoma, Melanoma.

Sponsors: Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University Health Melvin And Bren Simon Cancer Center?

Indiana University Health Melvin And Bren Simon Cancer Center has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University Health Melvin And Bren Simon Cancer Center conducted?

Indiana University Health Melvin And Bren Simon Cancer Center has 5 clinical trials on record. Their work covers Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line, Renal Cell Carcinoma, Melanoma.

Is Indiana University Health Melvin And Bren Simon Cancer Center accredited by Crixeo Health?

Indiana University Health Melvin And Bren Simon Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University Health Melvin And Bren Simon Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.